Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response. - Wikidata - wikimedia - TriplyDB

Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response.

Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response.

http://www.wikidata.org/entity/Q38150922

about

Serine racemase: a key player in apoptosis and necrosis Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease.Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer's Disease.S -ketamine compared to etomidate during electroconvulsive therapy in major depression.Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.NYX-2925 is a novel NMDA receptor-specific spirocyclic-β-lactam that modulates synaptic plasticity processes associated with learning and memory.Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.

P2860

Q27025560-7B510CCF-8AF5-433F-AA82-1DBE67BB6FE8 Q27025683-362CCC1C-6470-4300-9CEA-19AE8DCC4DA5 Q38286222-6A4BDCE4-B86B-4C44-8AB4-217BDE385F87 Q38686081-F32C0A25-6ACD-4421-BDF2-AC63346620E3 Q38770442-556BDF2F-3930-457D-BDBA-A010A0ECD79B Q38829511-E192FBF6-A654-4467-99A1-BC22D2F65FE9 Q38962796-EAE546D7-6ECA-4C08-818E-36343E57AF0B Q47383734-32FDD08A-E31F-4E44-B550-10D220694329 Q50435618-F3B1D566-C63E-4DBB-A147-221D73F44294 Q53377510-6A053D38-2640-4A4A-9928-E554CF2783B2

P2860

Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response.

http://www.wikidata.org/entity/Q38150922

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Memantine in patients with mod ...... istic definitions of response.

@en

type

label

Memantine in patients with mod ...... istic definitions of response.

@en

prefLabel

Memantine in patients with mod ...... istic definitions of response.

@en

P1433

Q38150922-3471DD7C-D613-4C42-8641-AB98DAD10C29

P1476

Q38150922-8BF83E88-8B18-48E6-997D-5A3A76AAD9BC

P2093

Q38150922-84A31749-5BF6-4BDE-B085-D3F96D0084DE

Q38150922-C2E91E8F-259A-44E2-B113-003F3D810624

Q38150922-F2BD3472-67B9-4E05-ADBC-77B8AE82BF37

P2860

Q38150922-066748A6-AC3D-40BE-BBED-70A0F80F60BD

Q38150922-0C110D88-3047-44BE-9B8D-966E9B40546F

Q38150922-0F19C763-870A-436E-8CF0-9F1FCD25D9CF

Q38150922-114CB4E6-14D1-41D5-A527-1FFC8E5168CD

Q38150922-12997C1E-0985-43E0-BB63-189FEB2BF727

Q38150922-172F5FE7-420B-472A-BEA8-39F57232A813

Q38150922-1EA4B977-ADD5-40F4-A6ED-427BAD66D333

Q38150922-20347086-0FEB-43E6-B4D0-ED4F7896BA3E

Q38150922-23969290-2A91-4A0E-86C7-7AE3372300A8

Q38150922-2468B98D-6123-4E2A-91F1-528D07A8C254

P304

Q38150922-AA923D04-CB82-4292-9866-F00E9DC66B07

P31

Q38150922-31c08c53-162f-4ad0-b838-719292a8426b

Q38150922-AADFD606-9B02-46EB-A916-F123F7F9F14A

P356

Q38150922-110E30E6-1882-452A-B413-71FCFDBE76D5

P433

Q38150922-1F886B58-1D09-4AC9-8771-8060B897D382

P478

Q38150922-1365D2F6-7637-4EAD-A058-FF5F43168CB4

P577

Q38150922-2B67B965-AE74-4320-938B-C247302236F3

P5875

Q38150922-1553294A-CC5B-4303-B109-435D7FF7894C

P698

Q38150922-F50B56ED-4309-47FD-ACBC-9D974DC0262B

P921

Q38150922-2037B609-44A3-49F4-8A3E-180BEB730975

P356

P1433

Dementia and Geriatric Cognitive Disorders

P1476

Memantine in patients with mod ...... istic definitions of response.

@en

P2093

Claus Goebel

http://www.w3.org/2001/XMLSchema#string

David Wilkinson

http://www.w3.org/2001/XMLSchema#string

Yvonne Wirth

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term course and effectiveness of combination therapy in Alzheimer disease

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.

Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials.

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.

Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies.

Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?

Donepezil and memantine for moderate-to-severe Alzheimer's disease.

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.

Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease.

Rivastigmine for Alzheimer's Disease: Improvement Versus Reduced Worsening.

P304

71-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000353801

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257597984

http://www.w3.org/2001/XMLSchema#string

P698

24107324

http://www.w3.org/2001/XMLSchema#string

P921